Published in PLoS One on February 24, 2014
Epigenetic silencing of Oct4 by a complex containing SUV39H1 and Oct4 pseudogene lncRNA. Nat Commun (2015) 0.95
Activation of the pluripotency factor OCT4 in smooth muscle cells is atheroprotective. Nat Med (2016) 0.93
Akt‑mediated phosphorylation of Oct4 is associated with the proliferation of stem‑like cancer cells. Oncol Rep (2015) 0.85
Pseudogenes in Human Cancer. Front Med (Lausanne) (2015) 0.81
Delineating the effects of 5-fluorouracil and follicle-stimulating hormone on mouse bone marrow stem/progenitor cells. Stem Cell Res Ther (2016) 0.80
The emerging roles of Oct4 in tumor-initiating cells. Am J Physiol Cell Physiol (2015) 0.76
FTH1P3, a Novel H-Ferritin Pseudogene Transcriptionally Active, Is Ubiquitously Expressed and Regulated during Cell Differentiation. PLoS One (2016) 0.75
Distinctive features of single nucleotide alterations in induced pluripotent stem cells with different types of DNA repair deficiency disorders. Sci Rep (2016) 0.75
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50
Core transcriptional regulatory circuitry in human embryonic stem cells. Cell (2005) 34.93
Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet (2000) 21.52
Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell (1998) 19.05
Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci U S A (2003) 4.67
A family of octamer-specific proteins present during mouse embryogenesis: evidence for germline-specific expression of an Oct factor. EMBO J (1989) 4.47
A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow. Leukemia (2006) 4.39
Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis (2004) 3.66
Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res (2008) 3.32
Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer (2005) 2.84
Molecular control of pluripotency. Curr Opin Genet Dev (2006) 2.75
Octamer binding proteins confer transcriptional activity in early mouse embryogenesis. EMBO J (1989) 2.70
Oct4 is required for primordial germ cell survival. EMBO Rep (2004) 2.56
Neuronal expression of neural nitric oxide synthase (nNOS) protein is suppressed by an antisense RNA transcribed from an NOS pseudogene. J Neurosci (1999) 2.49
POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res (2003) 2.45
Oct-4 expression in adult human differentiated cells challenges its role as a pure stem cell marker. Stem Cells (2007) 2.39
Oct4 pseudogenes are transcribed in cancers. Biochem Biophys Res Commun (2005) 2.34
Human embryonic genes re-expressed in cancer cells. Oncogene (2001) 2.26
Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells. Stem Cells (2006) 2.18
Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood: preliminary report. Leukemia (2006) 2.17
OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells. Stem Cells (2008) 1.95
Very small embryonic-like stem cells with maximum regenerative potential get discarded during cord blood banking and bone marrow processing for autologous stem cell therapy. Stem Cells Dev (2011) 1.95
The human OCT-4 isoforms differ in their ability to confer self-renewal. J Biol Chem (2006) 1.94
Fibroblast growth factor 2 modulates transforming growth factor beta signaling in mouse embryonic fibroblasts and human ESCs (hESCs) to support hESC self-renewal. Stem Cells (2006) 1.88
Oct4 and its pseudogenes confuse stem cell research. Cell Stem Cell (2007) 1.87
Multiple retropseudogenes from pluripotent cell-specific gene expression indicates a potential signature for novel gene identification. J Biol Chem (2005) 1.79
The pluripotency regulator Oct4: a role in somatic stem cells? Cell Cycle (2008) 1.79
In line with our ancestors: Oct-4 and the mammalian germ. Bioessays (1998) 1.79
A hypothesis for an embryonic origin of pluripotent Oct-4(+) stem cells in adult bone marrow and other tissues. Leukemia (2007) 1.77
Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology. Stem Cells (2010) 1.74
Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research. Biol Chem (2008) 1.72
OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer (2007) 1.68
Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues. Nucleic Acids Res (1992) 1.65
Human STELLAR, NANOG, and GDF3 genes are expressed in pluripotent cells and map to chromosome 12p13, a hotspot for teratocarcinoma. Stem Cells (2004) 1.56
Evidence that very small embryonic-like stem cells are mobilized into peripheral blood. Stem Cells (2008) 1.50
Stably transfected human embryonic stem cell clones express OCT4-specific green fluorescent protein and maintain self-renewal and pluripotency. Stem Cells (2005) 1.47
OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol (2007) 1.44
POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos. Stem Cells (2006) 1.43
Absence of OCT4 expression in somatic tumor cell lines. Stem Cells (2007) 1.41
Alternative translation of OCT4 by an internal ribosome entry site and its novel function in stress response. Stem Cells (2009) 1.33
Oct-4 mRNA and protein expression during human preimplantation development. Mol Hum Reprod (2005) 1.31
Oct-4 expression in inner cell mass and trophectoderm of human blastocysts. Mol Hum Reprod (2000) 1.20
A new role for expressed pseudogenes as ncRNA: regulation of mRNA stability of its homologous coding gene. J Mol Med (Berl) (2004) 1.16
Stem cell marker OCT3/4 in tumor biology and germ cell tumor diagnostics: history and future. Crit Rev Oncog (2006) 1.16
The POU5F1P1 pseudogene encodes a putative protein similar to POU5F1 isoform 1. Oncol Rep (2008) 1.09
An argument against a role for Oct4 in somatic stem cells. Cell Stem Cell (2007) 1.07
Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma. J Pathol (2011) 1.02
Restoration of skeletal muscle defects with adult human cells delivered on fibrin microthreads. Tissue Eng Part A (2011) 1.02
Induction of stem cell gene expression in adult human fibroblasts without transgenes. Cloning Stem Cells (2009) 1.00
Oct-4 expression in pluripotent cells of the rhesus monkey. Biol Reprod (2003) 1.00
In vivo osteoprogenitor potency of human stromal cells from different tissues does not correlate with expression of POU5F1 or its pseudogenes. Stem Cells (2008) 0.96
Constitutive expression of pluripotency-associated genes in mesodermal progenitor cells (MPCs). PLoS One (2010) 0.95
Oct-4, Rex-1, and Gata-4 expression in human MSC increase the differentiation efficiency but not hTERT expression. J Cell Biochem (2007) 0.92
FGF2-induced effects on transcriptome associated with regeneration competence in adult human fibroblasts. BMC Genomics (2013) 0.88
Human haematopoietic stem cells express Oct4 pseudogenes and lack the ability to initiate Oct4 promoter-driven gene expression. J Negat Results Biomed (2010) 0.84
A PCR/restriction digestion assay for the detection of the transcript variants 1 and 2 of POU5F1. Genes Chromosomes Cancer (2008) 0.84
Analysis of Oct-4 expression and ploidy in individual human blastomeres. Mol Hum Reprod (2001) 0.81
Collection and immunoselection of CD34+ cells: the impact of age, sex, and diabetes in patients with chronic heart failure. Transfusion (2016) 0.75
The effect of CD34(+) cell telomere length and hTERT expression on the outcome of autologous CD34(+) cell transplantation in patients with chronic heart failure. Mech Ageing Dev (2017) 0.75